Copyright © 2009  by "International Journal of Pharmaceutica Research and Development"  ·  All Rights reserved  ·  E-Mail: info@ijprd.com
Welcome to "International Journal of Pharmaceutical Research and Development"  i.e. "IJPRD"
HOW TO PREPARE   
YOUR PAPER
What's New | Feedback | Copyright and Disclaimer
Past Issues

March 2009

April 2009

May 2009

June 2009

July 2009

August 2009

September 2009

October 2009

November 2009


December 2009
Online Since : March 2009
Only 10 Articles will be Published in Each Issues
TODAY IS
Abstract Content
Model Abstract
Summary Content
Model Summary

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND DEVELOPMENT
Article No 6
October -2009 / Volume -
1 /Issue - 8/ Article No - 6 / Research Article


FORMULATION AND EVALUTION OF VENLAFAXINE HCL ENCLOSED IN ALGINATE MICROBEADS PREPARED BY IONTOPHORETIC GELLATION METHOD

      B. Bindu Madhavi1*, A. Ravinder Nath1, David Banji2,
R.Ramalingam1, M. Naga Madhu2,
G.Arjun2, V.Sriharsha3

IJPRD
B. Bindu Madhavi
1.Faculty of Technology, Osmania University, Hyderabad
2.Nalanda College of Pharmacy, Nalgonda.
3.Dr.Reddy’s laboratories Ltd, Bachupally, Hyderabad
Abstract

Venlafaxine hydrochloride (VEN) is a representative of a new class of antidepressants. Its higher solubility in water results in burst effect with sudden peak levels of drug in blood. The half lives of VEN and its active metabolite O-desmethyl venlafaxine are 5hr and 11hr respectively. The micro beads were prepared by the ionotropic gelation of sodium alginate in calcium chloride solution. The prepared micro beads were evaluated mainly for the sustain release of the drug apart from the other tests like, % drug encapsulation, particle size and drug polymer compatibility by the FTIR studies. The method had resulted in good encapsulation efficiency and micron sized alginate spheres. The drug release was found to be sustained for 16 hours and was found to follow the Korssmeyer Peppas kinetics.

Key words : Venlafaxine HCl, anti depressant activity, alginate micro beads, sustained release dosage forms.
[ VIEW FULL ARTICLE ] [ PDF VIEW ]